Tag: Masimo

All

Danaher to Acquire Masimo in Transaction Valued at $9.9 Billion

Masimo will become a standalone operating company within Danaher’s diagnostics segment, adding its pulse oximetry and patient monitoring technologies to the portfolio.

Masimo SET Pulse Oximetry Accurate Across Skin Tones in ICU Feasibility Study
Masimo Names New CEO
A Specific Brain Function Monitor Could Be Useful During DISE
Masimo Watch FDA-Cleared for Connectivity with Telemonitoring System
Masimo’s New Feature Brings Sleep Analysis to Wearables
FDA Clears Baby Monitoring System for OTC Use

All

The Health Equity Problem with Pulse Oximeters

Pulse oximeters risk inaccuracy in patients with dark skin, leading to potential missed sleep apnea diagnoses. Some pulse ox manufacturers explore more inclusive testing.